DNA Specificity Determinants Associate with Distinct Transcription Factor Functions by Hollenhorst, Peter C. et al.
DNA Specificity Determinants Associate with Distinct
Transcription Factor Functions
Peter C. Hollenhorst
1, Katherine J. Chandler
1, Rachel L. Poulsen
2, W. Evan Johnson
1,2, Nancy A. Speck
3,
Barbara J. Graves
1*
1Huntsman Cancer Institute, Department of Oncological Sciences, University of Utah, Salt Lake City, Utah, United States of America, 2Department of Statistics, Brigham
Young University, Provo, Utah, United States of America, 3Abramson Family Cancer Research Institute, Department of Cell and Developmental Biology, University of
Pennsylvania, Philadelphia, Pennsylvania, United States of America
Abstract
To elucidate how genomic sequences build transcriptional control networks, we need to understand the connection
between DNA sequence and transcription factor binding and function. Binding predictions based solely on consensus
predictions are limited, because a single factor can use degenerate sequence motifs and because related transcription
factors often prefer identical sequences. The ETS family transcription factor, ETS1, exemplifies these challenges. Unexpected,
redundant occupancy of ETS1 and other ETS proteins is observed at promoters of housekeeping genes in T cells due to
common sequence preferences and the presence of strong consensus motifs. However, ETS1 exhibits a specific function in T
cell activation; thus, unique transcriptional targets are predicted. To uncover the sequence motifs that mediate specific
functions of ETS1, a genome-wide approach, chromatin immunoprecipitation coupled with high-throughput sequencing
(ChIP-seq), identified both promoter and enhancer binding events in Jurkat T cells. A comparison with DNase I sensitivity
both validated the dataset and also improved accuracy. Redundant occupancy of ETS1 with the ETS protein GABPA
occurred primarily in promoters of housekeeping genes, whereas ETS1 specific occupancy occurred in the enhancers of T
cell–specific genes. Two routes to ETS1 specificity were identified: an intrinsic preference of ETS1 for a variant of the ETS
family consensus sequence and the presence of a composite sequence that can support cooperative binding with a RUNX
transcription factor. Genome-wide occupancy of RUNX factors corroborated the importance of this partnership.
Furthermore, genome-wide occupancy of co-activator CBP indicated tight co-localization with ETS1 at specific enhancers,
but not redundant promoters. The distinct sequences associated with redundant versus specific ETS1 occupancy were
predictive of promoter or enhancer location and the ontology of nearby genes. These findings demonstrate that diversity of
DNA binding motifs may enable variable transcription factor function at different genomic sites.
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Introduction
Transcriptional regulation of gene expression is programmed
through DNA sequence elements, termed promoters and enhanc-
ers. This genomic hard-wiring represents binding sites for
transcription factors that have sequence specific DNA recognition
and control development and homeostasis. Although the funda-
mental properties of protein-DNA recognition are well established,
the advent of powerful technologies that provide genome-wide
occupancy data has only recently allowed observation of these
interactions in vivo. The emerging picture is that no single sequence
motif fully explains all in vivo binding [1–3]. Furthermore, the in
vitro derived consensus motifs are often present in only a minority
of bound regions. These findings bring into question the purpose
of binding site sequence variations. Possibilities are illustrated by
experimental analysis of subsets of sites gathered from genomic
data. For example, the PHA4/FOXO binding sites that program
pharynx development in C. elegans differ in affinity, and thus carry
developmental programming information dictating time of
expression [4]. In yeast, PHO4 responsiveness to phosphate levels
is regulated by alterative sequence motifs that affect affinity and
program different roles for binding sites [5]. NF-kB and GR
binding site variants can alter the repressing or activating
transcriptional activity of the factor once it is bound [6,7]. The
challenge of genomic databases is how to take full advantage of the
vast number of binding sites, yet parse out functional consequences
of variation. To realize their full potential, genomic approaches to
transcriptional networks must go beyond a description of factor
occupancy to include correlates of functionality.
We focus on the transcription factor ETS1 that provides a
variety of contexts to address these central questions. ETS1 is a
member of the ETS family of transcription factors that display
similar DNA binding properties, including the recognition of a
core GGA(A/T) motif. ETS family members are extensively co-
expressed [8,9]. For example mRNA of 17 ets genes, including
ETS1, is present in Jurkat T cells. Despite overlapping expression
PLoS Genetics | www.plosgenetics.org 1 December 2009 | Volume 5 | Issue 12 | e1000778and sequence preferences, experimental data indicate that
individual ETS proteins have unique biological functions
[10–13]. For ETS1, mouse deletion studies indicate a critical role
in T cell activation [14]. This specific genetic function implies that
ETS1 has a unique mechanism that allows it, but not other ETS
proteins, to bind the promoters or enhancers of genes important
for T cell activation. Finally, ETS1 functions, in part, by
recruitment of the co-activator CBP to transcriptional control
regions, presumably functioning to activate genes at which it binds
[15–17]. We utilize this in depth understanding of ETS1 at both a
biochemical and biological level to inform our genomic approach
and facilitate functional analysis.
Initial genomic occupancy studies with ETS1 have provided
insight into the genomic dilemma and led to unexpected
observations. We previously identified two modes of ETS protein
targeting to promoters in Jurkat T cells using chromatin
immunoprecipitation and promoter microarrays (ChIP-chip).
The surprising mode is redundant occupancy in which a sequence
with the consensus CCGGAAGT is associated with occupancy of
three different ETS transcription factors: ETS1, GABPA
(GABPa), and ELF1. Because this sequence is consistent with
the in vitro derived consensus sequences derived from multiple ETS
family members, we concluded that it can alternately recruit
various ETS transcription factors. This redundant mode of
binding generally occurs in the promoters of housekeeping genes
and may represent shared function of the ETS family in the
maintenance of constitutive expression. The second ETS binding
mode is specific occupancy (e.g. ETS1, but not GABPA or ELF1),
which requires a GGA core motif, but is not associated with a close
match to the consensus ETS sequence. We proposed that specific
targets would mediate the specific biological functions of each ETS
transcription factor. However, the promoter-limited approach did
not identify a significant correlation between the specific targets of
ETS1 and genes important for the role of ETS1 in T cell
activation. Full investigation of this provocative dual role of the
ETS family required an expansion to full genome analysis.
In this study we identified regions across the entire human
genome occupied by ETS1, a DNA binding partner RUNX, and
co-activator CBP in Jurkat T cells to decipher sequence
determinants and investigate the biological significance of
sequence diversity. We discovered a previously undescribed role
for ETS1 at a large number of enhancers. Enhancer occupancy of
ETS1 was associated with a unique variant of the ETS binding site
and in vitro DNA binding assays illustrated how this variant
sequence functions as an ETS1 specificity determinant. Enhancers
co-occupied by ETS1 and RUNX contained a variant ETS
sequence closely juxtaposed to a RUNX binding site – a composite
sequence identical to that found in the T cell receptor enhancers.
These distinct enhancer sequences contrasted with prior observa-
tions of sequences at ETS1 bound promoters. Importantly, ETS1
bound regions that contained the ETS/RUNX composite
sequence were near genes important for T cell activation, thus
establishing a tissue-specific, genomic dataset for a factor
partnership. Furthermore, ETS1 was closely associated with
CBP occupancy at ETS1 specific enhancers, but not at
redundantly occupied promoters. By using genomic datasets for
DNA binding factors, in addition to correlates of DNase I sensitive
regions, histone marks, and co-factor binding, we decoded the
functionality of in vivo binding sequences.
Results
ETS1 and GABPA co-occupy active promoters, but ETS1
specifically occupies T cell enhancers
High-throughput sequencing coupled with chromatin immuno-
precipitation (ChIP-seq) facilitates genome-wide searches for
transcription factor binding sites [1]. We detected 19,420 bound
regions at an empirical false discovery rate of ,0.01 for ETS1 in
Jurkat T cells using this approach. This included almost all (94%)
of the 1086 ETS1 bound promoters previously identified by ChIP-
chip [18] plus an additional 6116 promoters, indicating a potential
for higher sensitivity. ETS1 bound promoter regions centered
within 500 bp of a transcription start site (TSS) (Figure S1);
therefore, a 500-bp limit was used for promoter definition. A large
number of regions, 12,283, were not in promoters. We sought to
establish the validity of these potential enhancer regions by
comparison to other types of genome-wide datasets. One powerful
dataset from primary CD4
+ T cells (thus comparable to the CD4
+
Jurkat cell line) identifies DNase I accessible regions as mapped by
high-throughput sequencing and ChIP-chip [19]. Based on the
long history of linkage of DNase I sensitivity to enhancers, we
screened ETS1 bound regions for overlap. 76% of ETS1 occupied
regions overlapped with DNase I sensitivity. (Overlap was 98% for
sites proximal to a TSS and 64% for distal sites.) This represents a
significant enrichment over the mean 4% overlap with datasets
randomly derived from control sequences (P,0.001, Figure 1A).
Randomly selected DNase I sensitive, ETS1 bound regions were
verified by quantitative PCR as ETS1 occupied (13 of 15 ETS1
bound, Figure S2), whereas regions that were not DNase I
sensitive included many apparent false positives (0 of 8 ETS1
bound, Figure S2). This strong correlation not only helped validate
the ETS1 data, but also suggested that DNase I sensitivity is a
strong correlate of robust ChIP signals. We proposed that the
14,824 ETS1 bound regions that overlap DNase I sensitive regions
represent functional regions, and only these were considered in
further analysis.
Datasets for histone marks in primary CD4
+ T cells [20] also
provide a measure of the activity of promoters and enhancers and
test for relevance of factor binding. For example, H3K4 tri-
methylation correlates with active promoters [21]. 86% of ETS1
Author Summary
Genomes contain sequences that encode both gene
products and the instructions for where and when each
gene is expressed. This gene expression code is critical for
normal development and goes awry in disease processes
such as cancer. The gene expression code is interpreted by
proteins called transcription factors that bind to particular
DNA sequences and carry instructions for gene activation
or repression. This recognition code is challenged by the
presence of highly-similar transcription factors that prefer
almost identical DNA sequences. In addition, studies in
living cells indicate that individual transcription factors
have significant flexibility in sequence recognition. Here,
we identify thousands of positions in the genome of
human T cells that are bound by the transcription factor
ETS1. These data, along with comparisons to other
genomic datasets, allow us to identify DNA sequences
that specify ETS1 binding while excluding binding of other
related transcription factors. Furthermore, we discover that
ETS1 binds more than one sequence and that these
sequence variants can predict distinct biological functions
of ETS1. Thus, this work contributes to our understanding
of the gene expression code by addressing both how a
transcription factor can bind unique genomic locations
and why a transcription factor binds multiple DNA
sequences.
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promoters without ETS1 (P,0.0001) (Table 1). Likewise, H3K4
mono-methylation is enriched in enhancers [21,22]. For DNase I
sensitive regions distal to a TSS, 52% with ETS1, but only 18%
without ETS1, had an H3K4 mono-methyl mark (P,0.0001)
(Table 1). Therefore, ETS1 occupancy is enriched at regions with
histone marks that areindicative ofenhancers and activepromoters.
Contrary to the expectation that family members with unique
genetic functions would have exclusive binding sites, we previously
discovered the majority of proximal promoters bound by ETS1,
are also occupied redundantly by other ETS proteins (e.g. GABPA
and ELF1). The small number of ETS1 specific sites identified
limited the robustness and fruitfulness of further analysis of this
class of targets [18]. Using a much larger ChIP-seq dataset that
Figure 1. Genomic occupancy of ETS1 overlaps with DNase I sensitivity and GABPA occupancy. (A) Overlap of genomic regions bound
by ETS1 in Jurkat T cells and regions found to be DNase I sensitive in CD4
+ T cells [19]. (B) Overlap of regions occupied by ETS1 and GABPA in Jurkat T
cells [23]. Only regions that overlap with DNase I sensitivity were included. (C) Log transformed P values of ETS1 and GABPA occupancy in a scanning
250 bp window mapped using the Integrated Genome Browser (http://igb.bioviz.org/) to regions of the human chromosome (Chr) indicated by
chromosomal coordinates (NCBI Build 36.1). Positions of Refseq genes are shown with genes transcribed from left to right above the nucleotide
position bar and genes in the opposite orientation below. Vertical lines (right) indicate the ETS/RUNX binding sequences previously tested for
function [27,44] in the TCRa enhancer (sequence GAGGATGTGGC) or the TCRb enhancer (sequence CAGGATGTGGT).
doi:10.1371/journal.pgen.1000778.g001
Table 1. Marks of enhancers and active promoters are associated with ETS1 occupancy.
Category
a Number
b H3K4me3
cd H3K4me1
cd CBP
d
Promoters occupied by ETS1 8236 86% 16% 75%
Promoters lacking ETS1 14,445 28% 11% 9%
DNase I sensitive promoters lacking ETS1 5961 58% 19% 20%
Distal DNase I sensitive regions occupied by ETS1 7501 46% 52% 68%
Distal DNase I sensitive regions lacking ETS1 77,141 10% 18% 5%
a Promoters are defined as 500 bp upstream and downstream of a RefSeq TSS. Distal regions are regions with the center greater than 500 bp from a RefSeq TSS. ETS1
occupied regions contain the center of an ETS1 bound region within the promoter or distal region. Totals differ from the number of ETS1 bound regions (Figure 1)
because in some cases multiple promoters or DNase I sensitive regions overlap with a single ETS1 bound region.
b The number of regions in the category.
c Positions of histone marks in CD4
+ T cells were determined by analyzing published ChIP-seq reads [20] with the Useq bioinformatics package.
d The percentage of regions in the category containing the indicated histone mark or CBP occupancy.
doi:10.1371/journal.pgen.1000778.t001
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mediate specific functions of ETS1. However, we first had to
identify which of the 14,824 ETS1 bound regions were redundant
sites, thus not strong candidates to mediate specific functions. We
analyzed genome-wide occupancy data reported for GABPA in
Jurkat cells [23] with the same methodology as our ETS1 analysis.
There were 7724 GABPA bound regions, of which 6443 were
redundantly bound by ETS1 (Figure 1B), illustrated graphically on
a genome section in Figure 1C (left). The remaining 8381 ETS1
specific regions were exemplified by the T cell receptor (TCR) a
and b enhancer loci (Figure 1C, right), which display ETS1, not
GABPA, occupancy. 67% of GABPA and ETS1 co-occupied
regions were proximal to a TSS consistent with previous findings
that discovered this dominant class of promoter binding events
[18]. In contrast, 68% of ETS1 specific regions were distal to the
nearest TSS indicating enhancer regions and are candidates to
mediate the specific functions of ETS1.
Genetic experiments have implicated ETS1 in T cell activation;
therefore, we predicted that genomic sites that specifically bind
ETS1 should be associated with genes necessary for T cell
function. The genes nearest to distal ETS1 bound regions were
assumed to be a reasonable estimate of ETS1 regulated genes.
This gene set was compared to genes with 20-fold higher mRNA
expression levels in CD4
+ T cells than the median expression in
multiple cell types (287 genes) and, as a control, to 268 genes
specific to pancreas (Figure 2). Compared to all genes, or pancreas
specific genes, genes that displayed T cell–specific expression were
more likely to be near one or more distal ETS1 bound regions.
Furthermore, as the number of nearby distal ETS1 bound regions
increased, the difference between the T cell–specific categories and
the control categories became more apparent. Thus, distal ETS1
binding was associated with a tissue-specific role of ETS1 in T
cells, further validating the functionality of ETS1 specific regions.
ETS1 occupancy of enhancers was associated with a
distinct sequence
At this point we had a dataset of ETS1 bound regions that
tracked with distal enhancer marks and T cell function. We sought
to determine whether such bound regions displayed a unique
sequence that would be responsible for ETS1 specific binding.
Unbiased searching for overrepresented sequences was performed
with the MEME algorithm [24]. ETS1 bound regions were
grouped according to proximity to the nearest TSS (proximal
versus distal) and specificity (redundant: overlap with GABPA;
specific: no overlap with GABPA) to provide experimental and
control datasets. The most over-represented sequence motifs in
redundant, proximal regions (Motif 1) and specific, proximal
regions (Motif 2) were identical to the motifs previously identified
in redundant and specific promoter proximal regions [18]. In
contrast, analysis of distal, specific ETS1 bound regions identified
a third, distinct motif (Motif 3) as the most over-represented
(Figure 3). The major differences from the ETS family consensus
(CCGGAAGT) present in Motif 1 were the almost exclusive
presence of an A at the second position and the inclusion, in some
instances, of a T at the sixth position (CAGGA(A/T)GT).
Therefore, specific ETS1 binding to enhancers is associated with
a sequence distinct from those found at ETS1 bound promoters.
A more directed bioinformatics approach assessed the impor-
tance of single nucleotide changes from the ETS consensus for
enhancer and promoter occupancy of ETS1. ETS1 bound regions
were partitioned into equally-sized sets of ETS1/GABPA
redundantly occupied promoters and ETS1 specific enhancers.
The number of occurrences of 8-mer sequences was reported
relative to the number of occurrences expected in a set of equally-
sized random sequences (Table 2). The ETS consensus sequence
(CCGGAAGT) was enriched in redundant promoters, but not in
ETS1 specific enhancers. The enrichment of every possible single
nucleotide change to the ETS consensus was then determined.
Only the change of the C at the second position to an A
(CaGGAAGT) resulted in a significant enrichment (P,0.0001) in
ETS1 specific enhancers. However, this sequence was also
enriched in redundant promoters. The A to T change at the sixth
position (CCGGAtGT) reduced significantly the enrichment in
redundant proximal regions (P,0.0001), but not distal regions
(P=0.3). Furthermore, the combination of both nucleotide
changes (CaGGAtGT) resulted in enrichment at ETS1 specific
enhancers (P,0.0001), but not redundant promoters (P=0.3).
Strikingly, a change of only two nucleotides inverted the
enrichment pattern at redundant promoters and ETS1 specific
enhancers. We concluded that the sequence CAGGATGT is a
specificity element for ETS1.
In considering specificity within families of transcription factors
the preference for a particular sequence may be due to intrinsic
DNA binding properties of different family members. To test the
ability of the two nucleotide changes to act alone or in
combination to select for ETS1 we measured the relative binding
affinity of ETS1 and second ETS factor, ELF1 which is also
reported to be active in T cells [25]. Indeed, ELF1 is present at
redundant, but not ETS1 specific promoters in Jurkat T cells in a
similar manner to GABPA [18]. Binding affinity for an ETS
consensus sequence, each single nucleotide variant, and the two
nucleotide variant was interrogated in vitro with purified proteins
by quantitative gel shift (Figure 4). The A to T change resulted in a
loss of affinity for ELF1 (3.6-fold loss), but not for ETS1. The C to
A change showed a modest effect on affinity and no discrimination
between ELF1 and ETS1 (1.9-fold versus 1.5-fold loss). In
contrast, the change of both nucleotides caused an 18.3-fold loss
of affinity for ELF1, but only a 2.4-fold loss for ETS1. We
Figure 2. Distal ETS1 bound regions are found near T cell–
specific genes. The frequency of neighboring, distal, ETS1 bound
regions was compared for three categories of genes; all Refseq genes,
CD4
+ T cell–specific genes, and pancreas specific genes. Tissue specific
gene lists were derived from the GNF SymAtlas database [52] and were
based on the level of mRNA in T cells or pancreas compared to the
median in all surveyed tissues with cutoffs (20-fold higher for T cells, 5-
fold higher for pancreas) that returned similar sized lists. The number of
genes in each category is indicated in parenthesis. Each ETS1 bound
region was matched to a single gene based on the nearest RefSeq TSS.
The percent of genes in each category associated with one or more
distal ETS1 bound regions (greater than 500 bp from the TSS) was
plotted.
doi:10.1371/journal.pgen.1000778.g002
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serves as a specificity determinant for ETS1 versus ELF1 due to an
intrinsic binding property of ETS1.
RUNX co-occupies enhancers with ETS1 through a
distinct sequence motif
Unique cooperative DNA binding between closely apposed
binding proteins can also drive specific occupancy of transcription
factors. A well-characterized partnership for ETS1 is with the
RUNX factors [26,27]. Interestingly, the consensus derived from
the most frequent nucleotides at each position of Motif 3
(CAGGAAGTGG) is similar to the sequences at the TCRb
(CAGGATGTGG) and TCRa (GAGGATGTGG) enhancers that
support cooperative binding of ETS1 with RUNX1 through an
ETS/RUNX composite sequence (RUNX consensus YGYGGY).
To test whether ETS1 bound enhancers were co-occupied by
RUNX factors, genome-wide occupancy of RUNX1/3 (RUNX)
was determined. Again, only regions that co-localized with DNase
I sensitivity were considered bound. Strikingly, 64% of the 1075
RUNX bound regions were co-occupied by ETS1. In contrast,
only 14% of RUNX bound regions were co-occupied by GABPA
(Figure 5A). 77% of the ETS1/RUNX co-occupied regions were
ETS1 specific and distal to a TSS (compared to 37% of ETS1
bound regions lacking RUNX), suggesting a role in T cell
enhancer function. An unbiased search with MEME for
overrepresented sequence motifs in regions co-occupied by
ETS1 and RUNX identified a motif (Motif 4) similar to Motif 3,
but with the RUNX binding site more strongly represented
(Figure 3). Like many sequence identification algorithms, MEME
is biased towards strongly preferred spacing distances between two
binding sites. To test whether other spacings of ETS and RUNX
sites were also over-represented in ETS/RUNX bound regions,
the distance from each ETS sequence to the nearest RUNX
sequence was plotted (Figure 5B). This analysis indicated that only
the spacing found by MEME was over-represented in these
regions. Therefore, ETS1 and RUNX co-occupy enhancer
regions in T cells through a composite ETS/RUNX binding site
similar to those found in the T cell receptor enhancers. These
findings indicate that pairing with a neighboring DNA binding
motif, in conjunction with intrinsic DNA binding properties, can
drive specificity.
Distinct sequence motifs are correlated with unique
modes of ETS1 occupancy
ETS1 occupancy of enhancers is associated with T cell–specific
genes (Figure 2) and ETS1 specific motifs (Motifs 3 and 4), whereas
promoter occupancy is associated with housekeeping genes [18]
and shows enrichment for sequences (Motif 1) that cannot
distinguish family members. The value of these motifs will be in
their predictive accuracy. All ETS1 bound regions were searched
for Motif 1 and Motif 4 with PATSER [28]. Regions containing
Motif 1 were more likely to be found in promoters, and regions
containing Motif 4 were more likely to be found in enhancers
(Table 3, Table S1). Associated genes, as determined by nearest
TSS, were searched for over-represented ontologies with the
GoMiner program [29]. Genes with Motif 4 were associated with
T cell activation categories, whereas those with Motif 1 were
associated with housekeeping ontologies (Table 3). Therefore, each
motif is predictive of the type of transcriptional control element
and class of ETS1 target gene.
CBP/p300 co-localizes with ETS1 at enhancers, but not at
promoters
The emerging differences for ETS1 at promoters versus
enhancers opened the possibility of distinct functions of ETS1 at
these loci. One mechanism of transcriptional activation by ETS1 is
the recruitment of the co-activators CBP and p300 [16].
Identification of p300 occupancy within the 30 mb ENCODE
region of the human genome revealed a greater proportion at
distal sites than at promoters [21], and p300 has been shown to
mark tissue specific enhancers in mice [30]. Thus, we proposed
that ETS1 would recruit CBP/p300 to T cell–specific enhancers,
but not promoters. Genome-wide occupancy for CBP detected
14,374 CBP bound/DNase I sensitive regions in Jurkat T cells.
Figure 3. Distinct sequence motifs are over-represented in different subsets of ETS1 bound regions. The indicated subsets of ETS1
bound regions were rank ordered by log transformed binomial P value and the top 250 regions were searched for over-represented sequences by
MEME [24]. The most over-represented position weight matrix for each subset is represented (E-values: Motif 1, 9.9610
2281; Motif 2, 2.8610
2287;
Motif 3, 8.8610
2105; Motif 4, 1.8610
2142). The height of each nucleotide indicates conservation at that position. Eight nucleotide positions in ETS
binding sites are numbered for reference. ETS bound regions were classified either proximal (center of region within 500 bp of a TSS) or distal (center
of region greater than 500 bp from a TSS). ETS1 bound regions were classified as redundant if they overlapped with a GABPA bound region and
specific if they did not. ETS1 bound regions were classified as RUNX co-occupied if they overlapped with a RUNX bound region.
doi:10.1371/journal.pgen.1000778.g003
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PLoS Genetics | www.plosgenetics.org 5 December 2009 | Volume 5 | Issue 12 | e1000778CBP bound regions showed a surprisingly high overlap with ETS1
bound regions at both redundant promoters (75%, P,0.0001) and
ETS1 occupied enhancers (68%, P,0.0001) compared to regions
not bound by ETS1 (Table 1). The strong presence of CBP
corroborated the general functionality of ETS1 binding sites.
Due to the unexpected equivalence of CBP overlap at both
enhancers and promoters we investigated the connection between
CBP binding and ETS1 function by a more detailed mapping
method that presented the two types of sites as a class average
(Figure 6A). At redundantly occupied promoters, the location of
ETS1, CBP, GABPA, H3K4 tri-methylation, and Motif 1 were
plotted relative to the TSS. At ETS1 occupied enhancers the
location of CBP, RUNX, H3K4 mono-methylation, and Motif 4
were plotted relative to the center of the ETS1 bound region. At
promoters ETS1 and GABPA binding were coincident with the
consensus ETS binding site at a position 25–30 bp upstream of the
transcription start site. This extremely TSS proximal location and
the location of histone H3K4 tri-methylation on either side of the
ETS1 bound region indicated that redundant ETS binding occurs
in the nucleosome-free region [31]. CBP occupancy was co-
incident with the downstream H3K4 tri-methyl, but not ETS1 and
GABPA binding, suggesting that CBP is not directly bound by
ETS factors at promoters. In contrast, at enhancers, CBP, ETS1,
and RUNX binding overlapped, suggesting that ETS1 and/or
RUNX may directly bind CBP. Again, ETS1 occupied a region
between histone marks, in this case H3K4 mono-methyl,
indicating that ETS1 binds between nucleosomes.
To test directly whether ETS1 was necessary for occupancy of
RUNX and CBP, ETS1 protein levels were knocked-down by two
independent shRNAs and occupancy was monitored by ChIP
(Figure 6B and 6C). Decreased ETS1 protein levels correlated
with a loss of ETS1, CBP, and RUNX ChIP enrichment at the
TCRb enhancer (containing Motif 4). We concluded that ETS1 is
critical for recruitment or stable binding of CBP in enhancers
important for T cell activation. In contrast, reduction of ETS1
occupancy in a redundantly occupied promoter (containing Motif
1) did not affect CBP enrichment. Thus, distinct sequence motifs
at ETS1 binding sites correlate with not only different types of
regulatory elements, but also distinct histone marks and co-
activator binding. We conclude that these sequences mediate
unique functions of ETS1.
Discussion
Comprehensive identification of ETS1 binding sites in Jurkat T
cells revealed that ETS1was present at a largenumber of enhancers
in a context distinct from that previously observed at promoters.
Enhancers differed from promoters in the sequence elements that
bind ETS1, in the compliment of neighboring proteins and histone
marks, and in the ontology of nearby genes. Specifically, the tissue
specific function of ETS1 correlated with enhancer binding via an
ETS/RUNX composite sequence. Furthermore, our data indicated
that thisT cell–specificenhancer function,butnot thehousekeeping
promoter function of ETS1, is associated with co-localization of the
co-activator CBP. Therefore, the sequences motifs identified here
areassociatedwith specific enhanceroccupancyofETS1and define
a different function than the sequence associated with redundant
ETS1 occupancy at promoters.
Overlap with DNase I sensitivity improves the accuracy of
a ChIP-seq dataset
Selecting regions at which ChIP-seq enrichment coincided with
DNase I sensitivity improved the accuracy of a dataset of
transcription factor bound regions. The fraction of regions
removed (24% of ETS1 bound regions, 39% of CBP bound
regions and 70% of RUNX regions) may reflect the quality of the
antibodies used for ChIP-seq. Removed regions had ETS1 binding
properties (presence of binding motifs, correlations with other
factors and histone marks), but at markedly lower levels than
retained regions. Thus, we propose that the use of DNase I
sensitivity screening improves the quality of a ChIP-seq dataset
and may be particularly useful for the interpretation of data
generated with suboptimal antibody reagents.
ETS1 binding determinants vary at specific enhancers
and redundant promoters
The genome-wide set of ETS1 binding sites showed sequence
variants that distinguish enhancer versus promoter binding events.
Specific ETS1 occupancy of enhancers was associated with a
sequence that varies by two nucleotides from the ETS consensus
sequence used for redundant binding at promoters. Our bioinfor-
Table 2. ETS1 occupancy of redundant promoters and
specific enhancers is associated with distinct sequences.
Sequence
a
Enrichment in redundant
and proximal regions
b
Enrichment in specific
and distal regions
b
CCGGAAGT 33 1
gCGGAAGT 15 1
aCGGAAGT 4 1
tCGGAAGT 2 0
CgGGAAGT 2 1
CaGGAAGT 10 14
CtGGAAGT 2 2
CCcGAAGT 1 0
CCaGAAGT 1 2
CCtGAAGT 1 1
CCGcAAGT 0 1
CCGaAAGT 0 0
CCGtAAGT 1 0
CCGGgAGT 2 0
CCGGcAGT 2 0
CCGGtAGT 1 0
CCGGAgGT 2 1
CCGGAcGT 2 0
CCGGAtGT 4 1
CCGGAAcT 4 0
CCGGAAaT 5 1
CCGGAAtT 1 0
CCGGAAGg 9 1
CCGGAAGc 23 1
CCGGAAGa 8 1
CaGGAtGT 1 10
a The ETS consensus from Motif 1 (Figure 3), every possible single nucleotide
change, and one double nucleotide change are shown.
b The number of occurrences of each octamer in equally-sized data sets of ETS1
bound, redundant, proximal regions and ETS1 bound, specific, distal regions
were counted. Enrichment was determined by dividing this number by the
expected number of occurrences of an octamer in random sequence space of
the same size and rounding to the nearest integer. All enrichment values
greater than two are significant, P,0.0001, Fisher’s exact test.
doi:10.1371/journal.pgen.1000778.t002
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equivalent (Table 2). The C to A change at the second position
appeared to be required for specific ETS1 binding to enhancers,
but also occurs at redundant promoters. In contrast, the A to T
change at the sixth position appeared to restrict occupancy of
redundant promoters, but not specific enhancers. The A to T
change has previously been shown to provide specificity for ETS1
versus the ETS protein ELF1 in vitro [32]. Our in vitro comparison
confirmed the role of this single nucleotide change and identified a
dramatic specificity difference between ETS1 and ELF1 when
both nucleotides were changed (Figure 4). However, the in vitro
data did not explain why the C to A change alone appeared
necessary for genomic enrichment in ETS1 specific enhancers
(Table 2). Therefore, the nucleotide preferences at these ETS
binding sequences are likely due to a combination of the intrinsic
differences in DNA binding attributes of ETS proteins and other in
vivo factors.
A striking difference between the ETS consensus sequence,
CCGGAAGT, and the C to A variant, CaGGAAGT, is the
susceptibility to DNA methylation. Indeed, methylation of this
CpG dinucleotide within the consensus has been shown to block
the binding of ETS proteins [33,34]. We have previously observed
a very strong correlation between redundant ETS occupancy of
promoters, the sequence CCGGAAGT and CpG islands [18].
The CpG islands at housekeeping promoters are generally
hypomethylated, whereas CpG dinucleotides distributed in lower
density throughout the genome are likely to be methylated [35,36].
Thus, ETS sites may be shielded from methylation at CpG island-
Figure 5. ETS1/RUNX co-occupancy correlates with specific spacing of ETS and RUNX binding sites. (A) Overlap of ETS1/RUNX and
GABPA/RUNX bound regions. The RUNX antibody was raised against the conserved DNA binding domain and does not differentiate between the
homologous RUNX1 and RUNX3 proteins present in T cells (N. Speck unpublished observation). (B) Spacing of ETS and RUNX binding sites in ETS1/
RUNX co-occupied regions. The 690 ETS1 bound regions that were co-occupied by RUNX were scanned for matches to the in vitro derived position
weight matrixes for ETS1 (M00032) and RUNX (M00271) from the Transfac database (http://www.biobase-international.com/index.php?id=transfac).
For each ETS1 sequence found, the distance to all forward oriented RUNX sequences in the same region were determined such that a RUNX site 59 to
an ETS site in the orientation CCGGAAGT was negative and 39 was positive. A similar mapping of RUNX sites in the reverse orientation returned no
spacing frequencies higher than five. The prominent peak at a spacing of five bp correlates with the spacing and orientation in the composite
sequence CAGGATGTGGT, from Motif 4 (Figure 3).
doi:10.1371/journal.pgen.1000778.g005
Figure 4. Intrinsic DNA binding affinity differences for ETS1 and ELF1. Full-length recombinant versions of the human ETS proteins ETS1
and ELF1 were purified from bacteria and assayed for affinity to radiolabeled oligonucleotides by gel-shift analysis. Datapoints represent the mean
and standard error of the mean of two replicates for ETS1 and three replicates for ELF1. Each KD was derived by curve fitting by nonlinear least-
squares analysis of equilibrium binding curves with fraction of DNA bound =1/(1+ KD/[ETS1]). The KD of ETS1 and ELF1 for the ETS consensus
sequence was 1.7610
29 and 1.7610
210 M, respectively. The fold decrease in affinity due to the A to T change, the C to A change, and the
combination of both changes were 1.0, 1.5, and 2.4 for ETS1 and 3.6, 1.9, and 18.3 for ELF1, respectively.
doi:10.1371/journal.pgen.1000778.g004
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change in the ETS binding sequences at enhancers may have
evolved to protect these sites from the repressive effects of DNA
methylation. Because other transcription factors whose binding
sites bear a CpG dinucleotide (NRF-1, BoxA, SP1, CRE, and E-
box) are also enriched in housekeeping promoters [37], the use of
an alternate sequence in tissue-specific enhancers may also extend
to these transcription factor families.
Another factor that might influence the ETS1 binding sequence
observed in vivo is the presence of closely juxtaposed binding sites for
other transcription factors. A subset of the ETS1 specific enhancers
were co-occupied by RUNX and had a composite ETS/RUNX
binding sequence(Motif 4).In the contextof this sequence, the A to T
change at the sixth position of the ETS sequence allows the RUNX
s e q u e n c et ob eac l o s e rm a t c ht ot h eR U N Xc o n s e n s u s( YGYGGT,
sixth position underlined). This factor could contribute to the
enrichment of the A to T change in specific enhancers. However, a T
at the sixth position was no more likely in regions co-occupied by
ETS1 and RUNX (Motif 4) than at ETS1 specific enhancers in
general (Motif3).This indicates that either an A or a T at this position
can support ETS1 and RUNX co-occupancy. Furthermore, only
55% of the ETS1 bound regions that had the sequence
CAGGATGT, had the full ETS/RUNX composite CAG-
GATGTGG. We propose that the remaining 45% of regions recruit
ETS1 either only through the ETS binding site, or in cooperation
with other unidentified transcription factors. In conclusion, the
sequences associated with ETS1 specific occupancy of enhancers
reflect intrinsic differences in DNA binding or interactions with other
factors and may be influenced by susceptibility to DNA methylation.
ETS1andRUNXco-occupancypredicttissue-specificenhancers
Mice with an ETS1 gene disruption have reduced numbers of
NK and NKT cells and show defects in T cell activation
[14,38,39]. RUNX genes are essential for NK, NKT, and T cell
differentiation [40–42]. However, the role of ETS1 and RUNX in
these immune functions has not been fully understood on the level
of individual target genes. Our data suggest that ETS1 and
RUNX regulate genes important for T cell activation pathways by
direct occupancy of nearby enhancers via a particular ETS/
RUNX binding site. The gene categories presented in Table 3
suggest that the primary role of these transcription factors is not
the direct activation of genes downstream of T cell receptor
signaling, but rather the control of expression of the signaling
machinery. This conclusion is consistent with the finding that
ETS1 null T cells are defective in activation upon receptor
stimulation, but respond normally to pharmacological stimulation,
which bypasses membrane proximal signaling events [39].
The strongest determinant of ETS1 specificity, Motif 4, fixed
the sequence of both ETS1 and RUNX binding sites as well as
spacing and relative orientation of the two sites (Figure 3 and
Figure 5). This strict conservation was somewhat surprising
because ETS1 and RUNX1 bind to DNA cooperatively in vitro
at a variety of other spacings and orientations [26,43]. Alternate
spacing can also function in transcription activation in vivo. For
example, the MMLV enhancer is activated by ETS1 and RUNX1
at a sequence in which the ETS and RUNX sites are four
nucleotides further apart than in Motif 4 [44]. Furthermore, Motif
2 can also support ETS1 and RUNX1 cooperativity in vitro [18].
Motif 2 utilizes much more divergent ETS and RUNX sequences
set two nucleotides further apart than in Motif 4. (Our analysis in
Figure 5 does not identify this spacing because these sequences are
too divergent from the Transfac ETS1 and RUNX motifs.)
However, only Motif 4, not Motif 2 or the MMLV enhancer
motif, was associated with ontologies aligned with T cell–specific
functions (Table 3, and data not shown). We speculate that this
spacing could have a function in addition to the simple
Table 3. ETS1 bound regions containing Motif 1 and Motif 4 have different characteristics.
Motif Regions
a Promoter
b Most overrepresented ontologies
c P value
d
4 1364 24% Leukocyte activation 7.6610
210
Phosphate metabolic process 9.9610
29
Cell activation 1.4610
28
Lymphocyte activation 3.1610
28
Protein amino acid phosphorylation 3.7610
28
T cell activation 1.2610
27
Positive regulation of lymphocyte activation 1.3610
27
Immune system process 1.9610
27
1 4492 59% Macromolecule metabolic process 4.9610
229
Biopolymer metabolic process 1.5610
226
Primary metabolic process 1.1610
220
Cellular metabolic process 1.7610
220
Gene Expression 2.3610
219
Nucleotide and nucleic acid metabolism 2.8610
218
Metabolic process 3.7610
217
RNA processing 7.3610
216
a Number of ETS1 bound regions containing a match to the PWM for Motif 1 and 4 as shown in Figure 3. PWM nucleotide frequencies and cutoffs are detailed in the
Materials and Methods and Table S2.
b Percentage of regions with the center within 500 bp of a RefSeq TSS.
c Regions were mapped to the nearest RefSeq gene and gene lists were analyzed by GoMiner. Overrepresented ontologies are listed in the order returned by GoMiner
with no editing.
d P value for each ontology category from GoMiner.
doi:10.1371/journal.pgen.1000778.t003
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for a specific conformation of ETS1 and RUNX for the
transcriptional activation function of these enhancers. For
example, because both ETS1 and RUNX can bind the co-
activator CBP [15,16,45], and CBP occupies the same position as
ETS1 and RUNX at enhancers (Figure 6A), cooperative CBP
recruitment may require this particular configuration of ETS1 and
RUNX.
A differential pattern of CBP enrichment at enhancers
and promoters
This first picture of genome-wide occupancy of a transcription
factor in combination with the co-factor CBP presented surprising
diversity. In spite of the general picture that CBP occupancy was
strongly correlated with ETS1 binding at both tissue specific
enhancers and at active promoters in Jurkat T cells (Table 1), fine
mapping uncovered a more complex picture (Figure 6A). The
coincident binding observed at enhancers and the sensitivity of
CBP occupancy at the TCRb enhancer to an ETS1 knockdown
(Figure 6C) is consistent with direct recruitment of CBP by ETS1
and/or RUNX. These data are consistent with reports that CBP/
p300 has a strong correlation with enhancers [21,30,46]. This not
only supports the functionality of ETS1 bound distal enhancers,
but also strongly demonstrates the role of DNA factors in CBP
recruitment. In contrast, the lack of concordance of ETS1 and
CBP binding events at promoters suggests that CBP is associated
with other factors at these sites. Potential CBP recruitment
mechanisms include interaction with general transcription factors
[47] and enhancer-promoter looping [48,49]. Either of these
mechanisms could contribute to the location of CBP at ETS1
bound promoters. We note, however, that the CpG island-
containing promoters of housekeeping genes, at which we observe
Figure 6. Distinct properties of promoters and enhancers occupied by ETS1. (A) Factor or histone modification positions were plotted as a
class average across redundant promoters (left) or ETS1 occupied enhancers (right). At redundant promoters, the occupancy profiles of ETS1, GABPA,
CBP, H3K4 tri-methyl, and Motif 1 were plotted from the center of each occupied region to the nearest RefSeq TSS. At ETS1-occupied enhancers, the
occupancy profiles of RUNX1, CBP, H3K4 mono-methyl, and Motif 4 were plotted with respect to the center of the ETS1 bound region. For each
factor, histone modification, or motif, a histogram of 30 bp bins was generated to represent the frequency of occupancy for each distance. The
number of occurrences at each distance was normalized to the total number of regions with an occurrence of each factor, histone modification, or
motif. A vertical line indicates the zero position of each chart (TSS or center of ETS1 bound region). (B) Protein immunoblot of Jurkat whole cell
extracts with the ETS1 antibody. Lane 1, no shRNA; Lane 2, negative control shRNA targeting luciferase; Lanes 3 and 4, two independent shRNAs (A
and B) targeting ETS1. The two bands apparent in Lanes 1 and 2 are consistent with the 51 and 42 kDa splicing isoforms of ETS1. (C) ETS1, CBP, and
RUNX ChIP enrichment at the TCRb enhancer and the RPS26 promoter. The shRNAs were expressed in Jurkat T cells prior to ChIP, as indicated. Two
independent biological replicates provided similar patterns, but different maximum levels of enrichment. A representative experiment is shown.
Primer sequences used are provided in Table S3.
doi:10.1371/journal.pgen.1000778.g006
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we suggest that CBP is brought to these promoters by enhancer-
independent interactions with the transcriptional machinery. One
possibility is that ETS1 participates in recruitment, but mainte-
nance at these constitutively active sites relies on cooperation with
basal machinery or modified histones.
Binding site sequence variation guides diverse roles for
transcription factors
Like many cellular proteins, transcription factors can have
multiple roles that vary based on cell type and condition.
Transcription factor function can also vary based on the context
of other proteins present at each genomic locus. Here we show
that the type of genes that are near ETS1 binding events, and the
location of the co-activator CBP differ based on the sequence that
recruits ETS1 to DNA. Thus, two different roles of ETS1 in T
cells – a role at housekeeping promoters, and one at tissue specific
enhancers – can be defined by distinct sequence motifs. The
sequence variation for different functions of a transcription factor
provides an explanation for the lack of a single binding sequence in
many genome-wide occupancy studies. Our investigation provides
a route to sort genome-wide binding data by the presence of such
sequence motifs and other correlative data to define the distinct
functions of a transcription factor.
Materials and Methods
ChIP
ChIP from Jurkat T cells was performed as described previously
[18]. In brief, 5610
7 cells were crosslinked with 1% formaldehyde
and sheared chromatin extract was prepared. Dynabeads
(Invitrogen) coupled to the appropriate secondary antibody were
used to immunoprecipitate extracts treated with one of the
following antibodies; polyclonal ETS1, sc-355; polyclonal CBP, A-
22; (Santa Cruz Biotechnology), or monoclonal RUNX, a3.2.3.1.
Crosslinks were reversed by heating and DNA was purified. Input
controls were prepared in parallel, but with no immunoprecipi-
tation step. qPCR analysis of ChIP DNA was performed as
described previously [18]. In brief, the level of each region was
determined by comparison to a standard curve of ChIP input
DNA. Enrichments are a ratio of the level of the target region in
each sample over the mean of the level of two negative control
genomic regions.
Computational methods
The software used for ChIP-seq analysis is open source and
available from the Useq project website (http://useq.sourceforge.
net). Human annotation and sequence were obtained from the
UCSC Genome Browser (March 2006, NCBI Build 36.1, HG18).
ChIP-seq analysis
ChIP and Input DNA was prepared for sequencing using
Illumina’s ChIP-seq kit. Each ChIP DNA sample was pooled from
three independent replicates. 36 bp reads were generated using
Illumina’s Genome Analyzer II and standard pipeline software.
The following software from the Useq package [50] was used to
identify regions enriched by ChIP compared to input control.
ElandParser mapped sequence reads to the genome with an
alignment score of .13 (210 log10 (0.05)). FilterPointData was
used to remove reads mapping to repeat regions included in the
satellite repeat track from the UCSC genome browser (http://
genome.ucsc.edu/). The number of non-repeat reads that mapped
to the human genome for each sequencing sample was 6,683,411
for ETS1, 9,509,960 for RUNX, 8,525,775 for CBP, and
13,825,035 for input. PeakShiftFinder was used to measure the
shift in the peak location between each DNA strand. ScanSeqs
used a sliding window of 250 bp to score for enrichment across the
genome and adjusted reads from opposite strands by 150 bp
(ETS1, RUNX), or 125 bp (CBP), to remove the peak shift bias.
EnrichedRegionMaker identified enriched regions. Significance
was determined by calculating a binomial P value for each 250 bp
window and controlled for multiple testing by calculating an
empirical false discovery rate. The ‘‘Best Window’’ in each
enriched region with an empirical false discovery rate of ,0.01
were called as ‘‘bound regions’’ and had a median size of 250 bp.
Bound regions were overlapped using the IntersectRegions tool
from Useq with no gap between regions except for overlaps
reported in Table 1 in which a gap up to 300 bp was allowed.
Enriched regions for ETS1, GABPA, and RUNX were screened
for intersection with DNase I sensitive regions [19] before further
analysis. This screening reduced the number of ETS1 bound
regions from 19,420 to 14,824, the number of GABPA bound
regions from 9214 to 7724, the number of CBP bound regions
from 23,757 to 14,374, and the number of RUNX bound regions
from 3632 to 1075. The P value for the overlap between ETS1
and DNase I sensitive sites was determined using IntersectRegions
and comparing the ETS1 overlap to the overlap of 1000 iterations
of a random regions of equivalent size derived from input point
data. The P values for overlaps shown in Table 1 were derived by
Fisher’s exact test. The nearest Refseq TSS was determined using
the FindNeighboringGenes tool. All ETS1 bound regions that
intersect with DNase I sensitive regions are provided in Table S1.
Table S1 also annotates the nearest gene, the presence or absence
of Motif 1, 2 or 4 (Figure 3) and overlapping GABPA, RUNX, and
CBP bound regions.
The ChIP-seq datasets and peak files are available for download
from NCBI’s Gene Expression Omnibus (GEO, http://www.ncbi.
nlm.nih.gov/geo), accession number GSE17954.
Protein purification and DNA binding assays
Protein purification and DNA binding assays were performed as
described previously[18]. In brief, full-length human cDNAs of ETS1
(p51) and ELF1 were cloned into pet28a (Novagen) with an N-
terminal 6x HIS tag, and expressed in bacteria. Proteins wereisolated
from inclusion bodies, resuspended in urea buffer (10 mM Tris
(pH 7.9), 4 M urea, 500 mM NaCl, 15 mM immidazole), and
bound to Ni-sepharose beads. After washing with urea buffer, protein
was eluted with urea buffer with 750 mM immidazole and dialyzed
overnight into 10 mM Tris (pH 7.9), 0.5 mM EDTA, 50 mM KCl,
1 mM DTT, and 10% glycerol. Protein concentration was
determined by comparison to BSA standards on Coomassie brilliant
blue stained SDS-PAGE gels. Three-fold serial dilutions of each
protein were incubated with
32P-labeled double stranded oligonucle-
otides (DNA concentration 1610
211)f o r3 0m i no ni c ea n dt h e n
run on a 6% polyacrylamide gel. Oligonucleotide probes had the
following sequences (59–39): GGCCAAGCCGGAAGTGTGTGG-
TAAACACTTT, GGCCAAGCCGGATGTGTGTGGTAAACA-
CTTT,
GGCCAAGCAGGAAGTGTGTGGTAAACACTTT,
GGCCAAGCAGGATGTGTGTGGTAAACACTTT. KDs
were calculated by measuring the radioactivity in unbound bands
by Phosphorimager (Molecular Dynamics) and using least squares
curve fit analysis with fraction of DNA bound =1/(1+ KD/
[Protein]).
Bioinformatic analysis by MEME, PATSER, and GOMINER
MEME (http://meme.sdsc.edu/meme4_1_1/cgi-bin/meme.
cgi) was run with default settings except the minimum motif
Specificity Determinants of ETS1
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For each set of regions, the 250 with the highest log-transformed
binomial P value for ETS1 were analyzed. Only the motif with the
lowest E-value was reported.
The position weight matrixes for each motif used in the
PATSER program (part of Regulatory Sequence Analysis Tools:
http://rsat.ulb.ac.be/rsat/) to identify matches in each ETS1
bound region are listed in Table S2. PATSER score cutoffs used
were Motif 1:9; Motif 2:12; Motif 4:10.3. Matches are listed in
Table S1.
GoMiner (http://discover.nci.nih.gov/gominer/) was used to
identify over-represented gene ontologies. All Refseq genes were
used as the ‘‘total’’ and each subset of Refseq genes was used as the
‘‘change’’ file. Default settings were used except ‘‘Evidence level 4’’
and ‘‘All/gene ontology’’ were selected.
ETS1 knockdown
Two distinct small-hairpin RNAs (shRNAs) targeting ETS1, or
a negative control shRNA targeting luciferase were cloned into
pMK0.1p [51] and introduced to Jurkat T cells by MMLV based
retroviruses. Jurkat T cells expressing the shRNA were selected by
puromycin resistance. The sequences targeted were: luciferase,
CTTACGCTGAGTACTTCGA; ETS1 A, AGGTGTAGACT-
TCCAGAAG; ETS1 B, CTGATGTAAGGCAATTAAT.
Supporting Information
Figure S1 ETS1 bound regions have a high density within
500 bp of a TSS. The distance from the center of each of the
19,420 ETS1 bound regions to the nearest Refseq TSS was
recorded. Distances were binned in 50 bp bins and frequencies
plotted for bins from 0 to 5,000. Distances greater than 5,000 were
discarded. 7,137 ETS1 bound regions had centers within 500 bp
of a TSS.
Found at: doi:10.1371/journal.pgen.1000778.s001 (2.64 MB TIF)
Figure S2 Validation of ChIP-seq results by Q-PCR analysis of
ChIP DNA. Enrichment was tested using primer sets specific for
each region (Table S1). The level of each region was determined
by comparison to a standard curve of ChIP input DNA.
Enrichments are a ratio of the level of the target region in each
sample over the mean of the level of two negative control genomic
regions. The enrichments shown are the mean and standard error
of the mean of two independent ChIP experiments. Regions were
considered bound that had an mean enrichment of equal to or
greater than 2. (A) 15 randomly selected ETS1 bound regions that
overlapped with a DNase I sensitive site in CD4+ T cells (1–15), 8
randomly selected ETS1 bound regions that did not overlap with a
DNase I sensitive site (16–23), and 9 randomly selected DNase I
sensitive regions that were not scored as ETS1 bound (24–32) were
tested for ETS1 ChIP enrichment in Jurkat T cells. Significantly
more (13 of 15) ETS1 bound/DNase I sensitive regions were
verified compared the other two categories to (0 of 8 and 0 of 9;
P,0.0001, Fisher’s exact test). (B) 10 of 10 randomly selected CBP
bound/DNase I sensitive regions were verified for CBP enrich-
ment. (C) 8 of 8 randomly selected RUNX bound/DNase I
sensitive regions were verified for RUNX enrichment.
Found at: doi:10.1371/journal.pgen.1000778.s002 (5.85 MB TIF)
Table S1 Properties of ETS1 bound regions. All chromosomal
regions identified as ETS1 bound that also overlapped with DNase
I sensitivity are listed. Regions that also overlapped with GABPA,
RUNX, or CBP are indicated. Regions that contained Motif 1, 2,
or 4 are indicated. The nearest RefSeq mRNA and gene, and the
distance to the TSS is shown. The binomial P value and empirical
false discovery rate reflect the significance of the ETS1 bound
region.
Found at: doi:10.1371/journal.pgen.1000778.s003 (3.54 MB
XLS)
Table S2 Position weight matrixes for Motif 1, 2, and 4.
Found at: doi:10.1371/journal.pgen.1000778.s004 (0.12 MB
DOC)
Table S3 Oligonucleotide primers used in this study.
Found at: doi:10.1371/journal.pgen.1000778.s005 (0.07 MB
DOC)
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